David Neujahr is a Respiratory physician affiliated with Emory Healthcare. OpenAlex indexes 93 publications with 1,463 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Properties of Mesenchymal Stem Cells in Lung Transplant
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
33.8%Macrolide Antimicrobial17.6%Azithromycin100%Part D≥51 patientsShort-acting sulfonamides8.1%Sulfamethoxazole-Trimethoprim100%Part D≥29 patients+ 3 more classes in this area
Cancer & immunology
23.5%Calcineurin inhibitor19.8%Tacrolimus95%Cyclosporine Modified5%Part D<11 patientsPurine Antimetabolite2.6%Azathioprine100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
21.3%Corticosteroid18.5%Prednisone100%Part D≥63 patientsProton pump inhibitor2.8%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2013 per NIH RePORTER. The latest:
- Dissecting the Pathways Leading to Injury in Lung Transplantation
Emory University
FY2013$128,736K08AI079166 - Dissecting the Pathways Leading to Injury in Lung Transplantation
Emory University
FY2012$128,736K08AI079166 - Dissecting the Pathways Leading to Injury in Lung Transplantation
Emory University
FY2011$128,736K08AI079166
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Allan Levey, MD, PhD
Emory Healthcare
James Lah, MD, PhD
Emory Healthcare
William Blum, MD
Emory Healthcare
Mehmet Bilen, MD
Emory Healthcare
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”